Micro ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion of lung cancer by regulating cyclooxygenase-2

Thoracic Cancer

Volumn 6, Issue 6, 2015, Pages 778-784

  Lv, Peng ^a   Zhang, Peng ^a   Li, Xin ^a   Chen, Yuan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

COX 2; Lung cancer; miRNA 101

Indexed keywords

CYCLOOXYGENASE 2; MICRORNA 101;

A549 CELL LINE; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG CANCER; MALE; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING;

EID: 84945484895     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12283     Document Type: Article

References (34)

1. Ridge CA, McErlean AM, Ginsberg MS. Epidemiology of lung cancer. Semin Intervent Radiol 2013; 30: 93-98.
2. Farh KK, Grimson A, Jan C etal. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 2005; 310: 1817-1821.
3. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
4. Lin C, Huang F, Zhang YJ, Tuokan T, Kuerban G. Roles of MiR-101 and its target gene Cox-2 in early diagnosis of cervical cancer in Uygur women. Asian Pac J Cancer Prev 2014; 15: 45-48.
5. Calin GA, Sevignani C, Dumitru CD etal. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004; 101: 2999-3004.
6. He L, Hannon GJ. MicroRNAs: Small RNAs with a big role in gene regulation. (Published erratum appears in Nat Rev Genet 2004; 5: 631) Nat Rev Genet 2004; 5: 522-531.
7. Wu AW, Gu J, Li ZF, Ji JF, Xu GW. COX-2 expression and tumor angiogenesis in colorectal cancer. World J Gastroenterol 2004; 10: 2323-2326.
8. Zeng W, van den Berg A, Huitema S, Gouw AS, Molema G, de Jong KP. Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma. PLoS ONE 2014; 9 (4): e95826.
9. Chakrabarty A, Tranguch S, Daikoku T, Jensen K, Furneaux H, Dey SK. MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci U S A 2007; 104: 15144-15149.
10. Karavitis J, Zhang M. COX2 regulation of breast cancer bone metastasis. Oncoimmunology 2013; 2 (3): e23129.
11. Wang HJ, Ruan HJ, He XJ etal. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 2010; 46: 2295-2303.
12. Zhang H, Qi F, Cao Y, Chen M, Zu X. Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis. Med Sci Monit 2014; 20: 812-817.
13. Thu KL, Chari R, Lockwood WW, Lam S, Lam WL. miR-101 DNA copy loss is a prominent subtype specific event in lung cancer. J Thorac Oncol 2011; 6: 1594-1598.
14. Shen Q, Bae HJ, Eun JW etal. MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer. Cancer Lett 2014; 344: 204-211.
15. Xu Y, An Y, Wang Y etal. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol Rep 2013; 29: 2019-2024.
16. Zhan P, Qian Q, Yu LK. Prognostic value of COX-2 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis. J Thorac Dis 2013; 5: 40-47.
17. Yin J, Wang M, Jin C, Qi Q. miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3-dependent apoptosis. Oncol Lett 2014; 7: 461-465.
18. Yang Y, Li X, Yang Q etal. The role of microRNA in human lung squamous cell carcinoma. Cancer Genet Cytogenet 2010; 200: 127-133.
19. Varambally S, Cao Q, Mani RS etal. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008; 322: 1695-1699.
20. Saki N, Abroun S, Soleimani M etal. Involvement of microRNA in T-cell differentiation and malignancy. Int J Hematol Oncol Stem Cell Res 2015; 9: 33-49.
21. Lee H, Park W, Ryu H, Jeon NL. A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation. Biomicrofluidics 2014; 8 (5): 054102.
22. Yang S, Gao Q, Jiang W. Relationship between tumour angiogenesis and expression of cyclo-oxygenase-2 and vascular endothelial growth factor-A in human renal cell carcinoma. J Int Med Res 2015; 43: 110-117.
23. Tyagi A, Agarwal C, Dwyer-Nield LD, Singh RP, Malkinson AM, Agarwal R. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells. Mol Carcinog 2012; 51: 832-842.
24. Zhang G, Panigrahy D, Hwang SH etal. Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Proc Natl Acad Sci U S A 2014; 111: 11127-11132.
25. Masferrer JL, Leahy KM, Koki AT etal. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000; 60: 1306-1311.
26. Cianchi F, Cortesini C, Bechi P etal. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 2001; 121: 1339-1347.
27. Leung WK, To KF, Go MY etal. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol 2003; 23: 1317-1322.
28. Hao Y, Gu X, Zhao Y etal. Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 2011; 4: 1073-1083.
29. Zheng F, Liao YJ, Cai MY etal. Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets. PLoS Genet 2015; 11 (2): e1004873.
30. Cho HM, Jeon HS, Lee SY etal. MicroRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp Ther Med 2011; 2: 963-967.
31. Guo F, Cogdell D, Hu L etal. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Oncol Rep 2014; 31: 2021-2028.
32. Lin X, Guan H, Li H etal. MiR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma. Biomed Rep 2014; 2: 122-126.
33. Lin S, Shao NN, Fan L, Ma XC, Pu FF, Shao ZW. Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR. J Huazhong Univ Sci Technolog Med Sci 2014; 34: 889-895.
34. Zhang Y, Guo X, Xiong L etal. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma. FEBS Lett 2012; 586: 4362-4370.